Cantor Fitzgerald analyst Olivia Brayer initiated coverage with a Hold rating on Alnylam Pharma (ALNY – Research Report) yesterday and set a ...
Hosted on MSN1mon
Cantor Fitzgerald maintains Vertex stock Overweight ratingTuesday, Cantor Fitzgerald reaffirmed its Overweight ... The firm's analyst, Olivia Brayer, provided insights into the pharmaceutical company's prospects, particularly focusing on the potential ...
Cantor Fitzgerald analyst Olivia Brayer maintained a Buy rating on MannKind (MNKD – Research Report) yesterday and set a price target of $9.00.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback